HAE, NYSE

Haemonetics Corporation (HAE)

Price (as of September 29)

74.55USD

Correlations

The correlation describes the statistical relationship between the value of two assets over time. Use this relationship to bet against an asset without shorting it or diversify your portfolio more effectively. Learn how you can use correlations to your advantage.

Lowest within Industry

Symbol Correlation

ANGO

AngioDynamics, Inc.

-0.03

AVGR

Avinger, Inc.

-0.03

EKSO

Ekso Bionics Holdings, Inc.

-0.02

AZTA

Azenta, Inc.

-0.02

BLFS

BioLife Solutions, Inc.

-0.02

ATR

AptarGroup, Inc.

-0

BDX

Becton, Dickinson and Company

-0

ALC

Alcon Inc.

-0

EL.PA

EssilorLuxottica Société anonyme

0

HOLX

Hologic, Inc.

0.01

Show more

Highest within Industry

Symbol Correlation

BLCO

Bausch + Lomb Corporation

0.17

DXR

Daxor Corporation

0.02

AKYA

Akoya Biosciences, Inc.

0.02

ATRI

Atrion Corporation

0.02

BAX

Baxter International Inc.

0.01

ATRC

AtriCure, Inc.

0.01

ISRG

Intuitive Surgical, Inc.

0.01

HOLX

Hologic, Inc.

0.01

EL.PA

EssilorLuxottica Société anonyme

0

ALC

Alcon Inc.

-0

Show more

Profile

Sector:
Healthcare
Industry:
Medical Instruments & Supplies

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital’s blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient’s overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.